JENNA MCCRACKEN: Open Payments
NPI 1679124374 · BETHEL PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 28 payments from 12 companies in 2025. Trend: 2023 $955 · 2024 $264 · 2025 $1,239
Food & beverage: $1,154Education: $85
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 6 | $599 |
| Boston Scientific Corporation | 3 | $165 |
| Astellas Pharma US Inc | 1 | $85 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| PFIZER INC. | 4 | $77 |
| ABBVIE INC. | 2 | $52 |
| Calyxo, Inc. | 2 | $51 |
| BIOPROTECT MEDICAL, INC. | 1 | $33 |
| IMMUNITYBIO, INC. | 2 | $32 |
| Endo USA, Inc. | 1 | $29 |
Products named: DAXXIFY, AMS 700, GEMTESA, XTANDI, BOTOX, CVAC ASPIRATION SYSTEM, BIOPROTECT BALLOON IMPLANT SYSTEM, ANKTIVA.
Industry payments across PA — which companies pay providers there.
